PRT-201

DRUG5 trials

Sponsors

Proteon Therapeutics

Conditions

Chronic Kidney DiseasePeripheral Artery Disease

Phase 1

A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients

CompletedNCT00679991

Proteon TherapeuticsChronic Kidney Disease

Start: 2008-11-30End: 2011-07-31Updated: 2015-04-30

A Study of PRT-201 Administered After Arteriovenous Graft (AVG) Creation in Patients With Chronic Kidney Disease

CompletedNCT01001351

Proteon TherapeuticsChronic Kidney Disease

Start: 2009-09-30End: 2012-11-30Updated: 2015-04-30

Pilot Study of PRT-201 Following Angioplasty in Patients With Peripheral Artery Disease (PAD)

CompletedNCT01616290

Proteon TherapeuticsPeripheral Artery Disease

Start: 2012-10-31End: 2015-07-31Updated: 2015-08-11

Phase 2

A Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease

CompletedNCT01305824

Proteon TherapeuticsChronic Kidney Disease

Start: 2011-03-31End: 2012-11-30Updated: 2015-04-30

Phase 3

A Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-1)

CompletedNCT02110901

Proteon TherapeuticsChronic Kidney Disease

Start: 2014-07-31End: 2018-12-31Updated: 2019-07-09

Related Papers

Evaluating the effectiveness of systemic heparin during arteriovenous fistula creation by emulating a target trial.

2025-03-013 citations

Evaluating national guideline concordance of recurrent interventions after radiocephalic arteriovenous fistula creation.

2022-12-2212 citations